Relay Therapeutics, Inc. (RLAY)

NASDAQ: RLAY · Real-Time Price · USD

17.36

-0.62 (-3.45%)

At close: Oct 13, 2026, 4:00 PM EDT

17.37

+0.01 (0.06%)

After-hours: Oct 13, 2026, 7:30 PM EDT

Relay Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,804	1,466	690	1,357	1,806	3,318
Market Cap Growth	239.47%	112.63%	-49.19%	-24.86%	-45.56%	-11.11%
Enterprise Value	2,924	903	-100	601	813	2,725
Last Close Price	17.36	8.46	4.12	11.01	14.94	30.71

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	367.57	95.49	68.91	53.13	1307.87	1095.42
PB Ratio	4.26	2.59	0.89	1.81	1.90	3.70
P/TBV Ratio	4.27	2.59	0.89	1.81	1.91	3.71

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	282.51	58.82	-	23.53	588.46	899.58

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.03	0.06	0.06	0.07	0.06	0.03
Net Debt / Equity Ratio	-0.99	-0.92	-0.94	-0.93	-0.99	-1.04
Net Debt / EBITDA Ratio	2.86	1.76	1.93	1.86	3.07	4.21
Net Debt / FCF Ratio	4.15	2.21	2.92	2.29	3.95	12.01
Asset Turnover	0.01	0.02	0.01	0.03	0.00	0.00
Quick Ratio	17.93	21.68	15.40	24.78	15.76	39.60
Current Ratio	18.27	22.61	15.95	25.44	16.00	40.14
Return on Equity (ROE)	-36.77%	-41.12%	-44.15%	-40.18%	-31.44%	-43.81%
Return on Assets (ROA)	-22.88%	-25.16%	-28.11%	-24.40%	-18.44%	-15.63%
Return on Capital Employed (ROCE)	-33.90%	-50.40%	-47.00%	-46.60%	-30.00%	-23.00%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-7.52%	-18.86%	-48.97%	-25.20%	-16.08%	-10.97%
FCF Yield	-5.58%	-16.09%	-36.41%	-22.43%	-13.21%	-2.35%
Buyback Yield / Dilution	-12.39%	-20.10%	-16.55%	-9.21%	-17.97%	-123.22%

SEC Filings: 10-K · 10-Q